Larimar Therapeutics plans PK run-in study in adolescents, children with FA
PremiumThe FlyLarimar Therapeutics plans PK run-in study in adolescents, children with FA
1M ago
Larimar Therapeutics reports Q2 EPS (34c), consensus (30c)
Premium
The Fly
Larimar Therapeutics reports Q2 EPS (34c), consensus (30c)
1M ago
LRMR Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
LRMR Upcoming Earnings Report: What to Expect?
1M ago
Larimar clinical hold removal ‘nice surprise,’ says William Blair
PremiumThe FlyLarimar clinical hold removal ‘nice surprise,’ says William Blair
4M ago
FDA removes hold on Larimar ‘s nomlabofusp program for FA
Premium
The Fly
FDA removes hold on Larimar ‘s nomlabofusp program for FA
4M ago
Larimar Therapeutics Announces FDA has Removed Partial Clinical Hold for Nomlabofusp Program in Friedreich’s Ataxia
Premium
Press Releases
Larimar Therapeutics Announces FDA has Removed Partial Clinical Hold for Nomlabofusp Program in Friedreich’s Ataxia
4M ago
Larimar Therapeutics initiated with an Outperform at Leerink
PremiumThe FlyLarimar Therapeutics initiated with an Outperform at Leerink
6M ago
5 Stocks that Analysts Love in March 2024
Premium
Market News
5 Stocks that Analysts Love in March 2024
6M ago
Larimar Therapeutics provides update on nomlabofusp development
Premium
The Fly
Larimar Therapeutics provides update on nomlabofusp development
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100